methoxypolyethylene glycol-epoetin beta (cera)

Italy

Drugs containing this active substance

  • MIRCERA

    It is prescribed to treat anemia caused by chronic kidney disease in adult and pediatric patients (from 3 months to 18 years of age) who are already receiving treatment with other erythropoiesis-stimulating agents and who have stabilized hemoglobin levels.

    Form: solution for injection

    Active substance Dosage
    methoxypolyethylene glycol-epoetin beta (cera) -

    ATC: B03XA03

    Manufacturer: ROCHE REGISTRATION GMBH